Pipeline

bonus 1a

Product Candidate

Discovery

Preclinical

Clinical Phase I/II

Clinical Phase III

Bone augmentation in osteoporosis patients

Preclinical

Novel nano-materials for drug delivery

Preclinical

Vascularized bone grafts

Preclinical

Soft tissue grafts

Preclinical

Bonus BioGroup developed innovative technologies to realize the full potential of adipose-derived stromal cells with a unique capacity to treat a broad spectrum of diseases involving tissue damage, inflammation, and autoimmunity.

bonus 1a

Image

CELL THERAPY

Cell therapies are a living pharmacy, able to deploy multiple therapeutics instead of single drugs.

Image

TISSUE ENGINEERING

It takes a village to grow a tissue, and one kind of cell is rarely enough.

 

INFORMATION FOR INVESTORS  |  CAREER OPPORTUNITIES  |  INFORMATION FOR PATIENTS   |   RESEARCH COLLABORATIONS & BUSINESS DEVELOPMENT INQUIRIES

INFORMATION FOR INVESTORS

CAREER OPPORTUNITIES

INFORMATION FOR PATIENTS

RESEARCH COLLABORATIONS & BUSINESS DEVELOPMENT INQUIRIES

BONUS BIOGROUP LTD.

Terms of Use | Privacy Policy

MAIL ICON  info@bonus-bio.com

MAIL ICON  +972 (0)73 206 7104

MAIL ICONMatam Advanced Technology
Park P.O.B 15143 Haifa 31905 Israel

you tube linkedin facebook twitter

© 2022 Bonus BioGroup Ltd. Created By Netron Israel Ltd

Please publish modules in offcanvas position.